Osmind scores $40M investment to aid in mental health research and treatment

Sad face depression

The Series B funding round was led by DFJ Growth. Osmind helps the medical community administer treatments, and track and study the effectiveness of those treatments for 14 million U.S. patients living with moderate and serious mental illness.